Thurmont, MD, United States of America

Jeffrey J Adamovicz

This inventor holds 1 USPTO granted patent. Top assignee: US Government as Represented by the Secretary of the Army. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey J Adamovicz. Retrieved from https://idiyas.com/inventor/jeffrey-j-adamovicz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeffrey J Adamovicz

Introduction

Jeffrey J Adamovicz is a notable inventor based in Thurmont, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions for the detection and treatment of infectious diseases.

Latest Patents

Adamovicz holds a patent for "Prophylactic and therapeutic monoclonal antibodies." This patent describes monoclonal antibodies that specifically recognize the V antigen and the epitopes associated with these antibodies. The invention includes mixtures of antibodies and methods for using them in the detection, prevention, and therapeutic treatment of plague infections, both in vitro and in vivo. He has 1 patent to his name.

Career Highlights

Jeffrey J Adamovicz is affiliated with the US Government as represented by the Secretary of the Army. His role involves significant research and development efforts aimed at enhancing public health and safety through innovative biomedical solutions.

Collaborations

Throughout his career, Adamovicz has collaborated with esteemed colleagues such as Tran C Chanh and Gerard P Andrews. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jeffrey J Adamovicz exemplifies the spirit of innovation in the field of biomedical research. His work on monoclonal antibodies represents a crucial advancement in the fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…